GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Shire PLC (NAS:SHPG) » Definitions » Effective Interest Rate on Debt %

Shire (SHPG) Effective Interest Rate on Debt % : 3.01% (As of Sep. 2018)


View and export this data going back to 1998. Start your Free Trial

What is Shire Effective Interest Rate on Debt %?

Effective Interest Rate on Debt % is the usage rate that a borrower actually pays on a debt. It is calculated as the positive value of Interest Expense divided by its average total debt. Total debt equals to Long-Term Debt & Capital Lease Obligation plus Short-Term Debt & Capital Lease Obligation. Shire's annualized positive value of Interest Expense for the quarter that ended in Sep. 2018 was $501 Mil. Shire's average total debt for the quarter that ended in Sep. 2018 was $16,631 Mil. Therefore, Shire's annualized Effective Interest Rate on Debt % for the quarter that ended in Sep. 2018 was 3.01%.


Shire Effective Interest Rate on Debt % Historical Data

The historical data trend for Shire's Effective Interest Rate on Debt % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shire Effective Interest Rate on Debt % Chart

Shire Annual Data
Trend Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17
Effective Interest Rate on Debt %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.46 3.62 3.40 3.82 2.72

Shire Quarterly Data
Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18
Effective Interest Rate on Debt % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.69 3.06 2.67 2.76 3.01

Competitive Comparison of Shire's Effective Interest Rate on Debt %

For the Biotechnology subindustry, Shire's Effective Interest Rate on Debt %, along with its competitors' market caps and Effective Interest Rate on Debt % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shire's Effective Interest Rate on Debt % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Shire's Effective Interest Rate on Debt % distribution charts can be found below:

* The bar in red indicates where Shire's Effective Interest Rate on Debt % falls into.



Shire Effective Interest Rate on Debt % Calculation

Shire's annualized Effective Interest Rate on Debt % for the fiscal year that ended in Dec. 2017 is calculated as

Effective Interest Rate on Debt %
=-1  *  Interest Expense/( (Total Debt  (A: Dec. 2016 )+Total Debt  (A: Dec. 2017 ))/ count )
=-1  *  -578.9/( (22967.8+19541.1)/ 2 )
=-1  *  -578.9/21254.45
=2.72 %

where

Total Debt  (A: Dec. 2016 )
=Long-Term Debt & Capital Lease Obligation + Short-Term Debt & Capital Lease Obligation
=19899.8 + 3068
=22967.8

Total Debt  (A: Dec. 2017 )
=Long-Term Debt & Capital Lease Obligation + Short-Term Debt & Capital Lease Obligation
=16752.4 + 2788.7
=19541.1

Shire's annualized Effective Interest Rate on Debt % for the quarter that ended in Sep. 2018 is calculated as

Effective Interest Rate on Debt %
=-1  *  Interest Expense/( (Total Debt  (Q: Jun. 2018 )+Total Debt  (Q: Sep. 2018 ))/ count )
=-1  *  -500.8/( (17914.9+15346.7)/ 2 )
=-1  *  -500.8/16630.8
=3.01 %

where

Total Debt  (Q: Jun. 2018 )
=Long-Term Debt & Capital Lease Obligation + Short-Term Debt & Capital Lease Obligation
=16722 + 1192.9
=17914.9

Total Debt  (Q: Sep. 2018 )
=Long-Term Debt & Capital Lease Obligation + Short-Term Debt & Capital Lease Obligation
=11098 + 4248.7
=15346.7

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Effective Interest Rate on Debt %, the Interest Expense of the last fiscal year and the average total debt over the fiscal year are used. In calculating the quarterly data, the Interest Expense data used here is four times the quarterly (Sep. 2018) interest expense data. Effective Interest Rate on Debt % is displayed in the 30-year financial page.


Shire  (NAS:SHPG) Effective Interest Rate on Debt % Explanation

Effective Interest Rate on Debt % measures the usage rate that a borrower actually pays on a debt.


Shire Effective Interest Rate on Debt % Related Terms

Thank you for viewing the detailed overview of Shire's Effective Interest Rate on Debt % provided by GuruFocus.com. Please click on the following links to see related term pages.


Shire (SHPG) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Shire PLC (NAS:SHPG) » Definitions » Effective Interest Rate on Debt %
Traded in Other Exchanges
N/A
Address
Shire is a diversified, Ireland-based specialty drug firm. Shire has grown primarily through mergers and acquisitions, including the Transkaryotic Therapies acquisition in 2005, which established its genetic disease business with Replagal and Elaprase, and the merger with New River in 2007, which brought full rights to neuroscience drug Vyvanse. Shire completed the acquisition of ViroPharma (genetic diseases) in 2014, NPS Pharma (internal medicine) in 2015, and Baxalta (hematology, immunology, and oncology) and Dyax (genetic diseases) in 2016.
Executives
James H Cavanaugh director 265 HOTHORPE LANE, VILLANOVA PA 19085

Shire (SHPG) Headlines

From GuruFocus

Takeda Closes In on Shire, But It's Not a Done Deal Yet

By John Engle John Engle 05-08-2018

4 Stocks John Paulson and Paul Tudor Jones Agree On

By Sydnee Gatewood Sydnee Gatewood 09-21-2018